<i><scp>ALK</scp></i> and <i>ROS1</i> rearrangements tested by fluorescence <i>in situ</i> hybridization in cytological smears from advanced non‐small cell lung cancer patients

Abstract

Whenever cytology represents the only available material for diagnosis and biological characterization of NSCLC, minimally invasive procedures may provide an additional important source of cellular material for FISH assessment of ALK and ROS1 rearrangements.